|
1
|
Barzi A and Thara E: Angiogenesis in
esophageal and gastric cancer: A paradigm shift in treatment.
Expert Opin Biol Ther. 14:1319–1332. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray FI and Devesa SS: Cancer
burden in the year 2000. The global picture. Eur J Cancer. 37 Suppl
8:S4–S66. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liotta LA and Kohn E: Anoikis: Cancer and
the homeless cell. Nature. 430:973–974. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nagaprashantha LD, Vatsyayan R, Lelsani
PC, Awasthi S and Singhal SS: The sensors and regulators of
cell-matrix surveillance in anoikis resistance of tumors. Int J
Cancer. 128:743–752. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bailey JM, Singh PK and Hollingsworth MA:
Cancer metastasis facilitated by developmental pathways: Sonic
hedgehog, Notch, and bone morphogenic proteins. J Cell Biochem.
102:829–839. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang JP, Li N, Bai WZ, Qiu XC, Ma BA,
Zhou Y, Fan QY and Shan LQ: Notch ligand Delta-like 1 promotes the
metastasis of melanoma by enhancing tumor adhesion. Braz J Med Biol
Res. 47:299–306. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sethi N, Dai X, Winter CG and Kang Y:
Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast
cancer by engaging notch signaling in bone cells. Cancer Cell.
19:192–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tao J, Erez A and Lee B: One NOTCH
further: Jagged 1 in bone metastasis. Cancer Cell. 19:159–161.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xing F, Okuda H, Watabe M, Kobayashi A,
Pai SK, Liu W, Pandey PR, Fukuda K, Hirota S, Sugai T, et al:
Hypoxia-induced Jagged2 promotes breast cancer metastasis and
self-renewal of cancer stem-like cells. Oncogene. 30:4075–4086.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang Y, Ahn YH, Gibbons DL, Zang Y, Lin W,
Thilaganathan N, Alvarez CA, Moreira DC, Creighton CJ, Gregory PA,
et al: The Notch ligand Jagged2 promotes lung adenocarcinoma
metastasis through a miR-200-dependent pathway in mice. J Clin
Invest. 121:1373–1385. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu Y, Su H, Li X, Guo G, Cheng L, Qin R,
Qing G and Liu H: The NOTCH ligand JAGGED2 promotes pancreatic
cancer metastasis independent of NOTCH signaling activation. Mol
Cancer Ther. 14:289–297. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li W, Liu M, Feng Y, Huang YF, Xu YF, Che
JP, Wang GC and Zheng JH: High expression of Notch ligand Jagged2
is associated with the metastasis and recurrence in urothelial
carcinoma of bladder. Int J Clin Exp Pathol. 6:2430–2440.
2013.PubMed/NCBI
|
|
14
|
Huang QB, Ma X, Li HZ, Ai Q, Liu SW, Zhang
Y, Gao Y, Fan Y, Ni D, Wang BJ and Zhang X: Endothelial Delta-like
4 (DLL4) promotes renal cell carcinoma hematogenous metastasis.
Oncotarget. 5:3066–3075. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kontomanolis E, Panteliadou M,
Giatromanolaki A, Pouliliou S, Efremidou E, Limberis V, Galazios G,
Sivridis E and Koukourakis MI: Delta-like ligand 4 (DLL4) in the
plasma and neoplastic tissues from breast cancer patients:
Correlation with metastasis. Med Oncol. 31:9452014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiao M, Yang S, Ning X and Huang Y:
Aberrant expression of δ-like ligand 4 contributes significantly to
axillary lymph node metastasis and predicts postoperative outcome
in breast cancer. Hum Pathol. 45:2302–2310. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
NIH requests information on care of
laboratory animals. Am J Vet Res. 67:204–205. 2006.PubMed/NCBI
|
|
18
|
Reinacher-Schick A, Pohl M and Schmiegel
W: Drug insight: Antiangiogenic therapies for gastrointestinal
cancers - focus on monoclonal antibodies. Nat Clin Pract
Gastroenterol Hepatol. 5:250–267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ridgway J, Zhang G, Wu Y, Stawicki S,
Liang WC, Chanthery Y, Kowalski J, Watts RJ, Callahan C, Kasman I,
et al: Inhibition of DLL4 signalling inhibits tumour growth by
deregulating angiogenesis. Nature. 444:1083–1087. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sainson RC and Harris AL: Anti-DLL4
therapy: Can we block tumour growth by increasing angiogenesis?
Trends Mol Med. 13:389–395. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang S, Liu Y, Xia B, Deng J, Liu T, Li Q,
Yang Y, Wang Y, Ning X, Zhang Y and Xiao M: DLL4 as a predictor of
pelvic lymph node metastasis and a novel prognostic biomarker in
patients with early-stage cervical cancer. Tumour Biol.
37:5063–5074. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Z, Da Silva TG, Jin K, Han X,
Ranganathan P, Zhu X, Sanchez-Mejias A, Bai F, Li B, Fei DL, et al:
Notch signaling drives stemness and tumorigenicity of esophageal
adenocarcinoma. Cancer Res. 74:6364–6374. 2014. View Article : Google Scholar : PubMed/NCBI
|
